If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.50
Bid: 109.50
Ask: 110.50
Change: -0.50 (-0.45%)
Spread: 1.00 (0.913%)
Open: 114.50
High: 114.50
Low: 110.50
Prev. Close: 111.00
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update

20 Nov 2023 07:00

RNS Number : 9013T
McBride PLC
20 November 2023
 

20 November 2023

 

McBride plc

 

AGM Trading Update

 

McBride plc (the "Group"), the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning and hygiene markets, today provides the following trading update ahead of its 2023 Annual General Meeting.

 

Our trading update on 19 October 2023 outlined that despite upward pressures in non-material costs, stronger than expected sales volumes and relatively stable raw material and packaging material costs meant that the Group traded ahead of its internal forecasts for the first quarter.

 

The Group has continued to trade ahead of our expectations in October and the early part of November, mostly a result of the continuing consumer shift to value driving strong demand for our high-quality private label products from our retail partners. For the first four months of the current financial year, overall volumes were 8.2% higher compared to prior year, with private label volumes growing 11.7%.

 

Net debt reduction is progressing well and at our half year of 31 December 2023 we expect to be fully compliant with debt cover and interest cover banking covenants, some nine months ahead of when testing recommences in September 2024. By our year end of 30 June 2024, we anticipate net debt / adjusted EBITDA will be close to 2x.

 

With only four months of the financial year complete, the Group remains alert to the possible risk to full year results from world events which could lead to macro-economic instability and potential increased volatility in commodity markets and ultimately into further input cost pressures.

 

 

For further information:

 

McBride plc

Chris Smith, Chief Executive Officer

Mark Strickland, Chief Financial Officer

 

0161 203 7401

Instinctif Partners

Guy Scarborough

Bryn Woodward

0207 457 2020

 

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulations which came into effect on 3 July 2016.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEADFPFSLDFFA
Date   Source Headline
30th Aug 20224:35 pmRNSPrice Monitoring Extension
25th Aug 20226:22 pmRNSCorrection - Result of General Meeting
25th Aug 20224:40 pmRNSResult of AGM
22nd Aug 20223:41 pmRNSHolding(s) in Company
15th Aug 20225:48 pmRNSHolding(s) in Company
9th Aug 20227:00 amRNSNotice of General Meeting
14th Jul 20227:00 amRNSFull year trading update
29th Jun 20227:00 amRNSJune 2022 - Bank Covenant Waiver
17th Jun 20224:42 pmRNSSecond Price Monitoring Extn
17th Jun 20224:36 pmRNSPrice Monitoring Extension
9th Jun 20221:55 pmRNSDirector/PDMR Shareholding
24th May 20223:20 pmRNSDirector/PDMR Shareholding
23rd May 202212:31 pmRNSDirector/PDMR Shareholding
13th May 20227:00 amRNSDirector/PDMR Shareholding
25th Apr 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20221:19 pmRNSDirector/PDMR Shareholding
18th Mar 202210:05 amRNSDirector/PDMR Shareholding
7th Mar 202210:03 amRNSDirector/PDMR Shareholding
28th Feb 20225:47 pmRNSDirector/PDMR Shareholding
24th Feb 20225:40 pmRNSDirector/PDMR Shareholding
22nd Feb 20227:00 amRNSHalf-year Report
18th Feb 20227:00 amRNSBoard Changes
22nd Dec 20213:02 pmRNSDecember 2021 - Bank Covenant Waiver
16th Dec 20217:00 amRNSFinancial Year 2022 Trading Update
26th Nov 20219:48 amRNSDirector/PDMR Shareholding
26th Nov 20217:00 amRNSRedemption of B Shares
8th Nov 20212:02 pmRNSDirector/PDMR Shareholding
26th Oct 20213:01 pmRNSDirector/PDMR Shareholding
26th Oct 20212:21 pmRNSDirector/PDMR Shareholding
26th Oct 20211:35 pmRNSDirector/PDMR Shareholding
19th Oct 20216:05 pmRNSResult of AGM
19th Oct 20217:00 amRNSAGM Trading Update
7th Oct 20213:05 pmRNSDirector/PDMR Shareholding
5th Oct 20216:21 pmRNSCorrection to the Annual Report
30th Sep 20216:16 pmRNSRedemption of B Shares
24th Sep 20217:00 amRNSAnnual Report 2021 and Annual General Meeting 2021
13th Sep 20213:27 pmRNSDirector/PDMR Shareholding
7th Sep 20214:05 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSFinal Results
2nd Sep 20215:00 pmRNSTransaction in Own Shares
1st Sep 20215:29 pmRNSTransaction in Own Shares
31st Aug 20215:14 pmRNSTransaction in Own Shares
25th Aug 20215:18 pmRNSTransaction in Own Shares
24th Aug 20215:09 pmRNSTransaction in Own Shares
23rd Aug 20215:33 pmRNSTransaction in Own Shares
20th Aug 20215:00 pmRNSTransaction in Own Shares
19th Aug 20215:49 pmRNSTransaction in Own Shares
19th Aug 20217:00 amRNSFinancial Year 2022 trading update
14th Jul 20217:00 amRNSFull year trading update
9th Jul 20211:27 pmRNSReplacement: Directorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.